Pay in 4 interest-free payments of $6.66 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
As of 2026, retatrutide has not received marketing authorisation from the MHRA or EMA and is only accessible within authorised clinical trials
The purpose is maintaining optimal levels while the body completes the deeper structural repair that takes longest
Entering a target dose of 1,000mcg (1.0mg) will show that 0.2mL, or 20 units on a U-100 syringe, is needed
The provider still must satisfy all prescribing and documentation obligations
US$ 25.06
US$ 24.72
US$ 20.73
US$ 27.83
US$ 21.10
US$ 24.70
US$ 28.03
US$ 24.10
US$ 22.09
US$ 22.47
